Skip to content

Electrifying Precision: Testing a New Nerve Monitoring Method in Thyroid Operations

Comparison of safety and efficacy of innovative thyroid cartilage needle electrodes with standard neural integrity monitor endotracheal tube for intra-operative nerve monitoring during thyroidectomy surgeries- a randomized clinical trial. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093695
Enrollment
60
Registered
2025-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Thyroid Cartilage Needle Electrodes: These are novel electrodes which will be placed onto thyroid cartilage for intra-operative nerve monitoring Control Intervention1: Neural Integrity

Sponsors

Dr Rohit Bhondekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled to undergo thyroidectomy surgery. 2. Adults aged 18 years and above. 3. Patients willing to participate in the randomized clinical trial and provide informed consent. 4. Individuals with a willingness to engage in postoperative follow-up assessments to evaluate the long-term efficacy and safety of the novel electrode techniques compared to standard approaches. 5. Patients without significant abnormalities in vocal cord function or laryngeal anatomy that would preclude the use of IONM electrodes.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to thyroidectomy surgery. 2. Patients with pre-existing vocal cord dysfunction or laryngeal pathology. 3. Individuals enrolled in other clinical trials concurrently. 4. Pregnant women or those planning to become pregnant during the study period. s. Patients with significant comorbidities that may affect surgical outcomes or intraoperative neuromonitoring, such as severe cardiopulmonary disease or neurological disorders. 6. Individuals enrolled in other clinical trials concurrently.

Design outcomes

Primary

MeasureTime frame
1.Efficacy & Safety profile, including intraoperative complications and postoperative adverse events. Timepoint: Intraoperatively and at 3 months and 6 months

Secondary

MeasureTime frame
1. Incidence of recurrent laryngeal nerve (RLN) injury. 2. Signal quality & reliability comparison. 3. Patient-reported outcomes related to voice quality, swallowing function, & overall satisfaction. Timepoint: At baseline, 3 & 6 months

Countries

India

Contacts

Public ContactDr Rohit Bhondekar

AIIMS Nagpur

sandyent@aiimsnagpur.edu.in9860529979

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026